莪术油口服吸收机理及制剂前研究10.docx

莪术油口服吸收机理及制剂前研究10.docx

《莪术油口服吸收机理及制剂前研究10.docx》由会员分享，可在线阅读，更多相关《莪术油口服吸收机理及制剂前研究10.docx（11页珍藏版）》请在冰豆网上搜索。

莪术油口服吸收机理及制剂前研究10

bibliography

[1]TheStatePharmacopeiaCommissionofPeople’sRepublicofChina,PharmacopeiaofthePeople’sRepublicofChina.Vol.I,ChemicalIndustryPress,Beijing,2005,p.194.

[2]NIEG,JIANGY,LIZS,etal.InfluenceoffourcomponentsofEzhuongeneexpressionofhepaticstellatecell-T6[J].ChinJTCMWMCritCare,2005,12（3）:

135-139.

[3]YOUJ,CUIFD,LIQP,etal.Anovelformulationdesignaboutwater-insolubleoilydrug:

preparationofzedoaryturmericoilmicrospherewithself-emulsifyingandevaluationinrabbits[J].InternationalJournalofPharmaceutics,2005,288:

315-323.

[4]WANGYZ,DENGYH,MAOSR,etal.Characterizationandbodydistributionofβ-elemenesolidlipidnanoparticles（SLN）[J].DrugDevelopmentandIndustrialPharmacy,2005,31:

769-778.

[5]DENGCH,JIJ,LIN,etal.Fastdeterminiationofcurcumol,curdioneandgermacroneinthreespeciesofCurcumarhizomesbymicrowave-assistedextractionfollowedbyheadspacesolid-phasemicroextrationandgaschromatography-massspectrometry[J].JournalofChromatographyA,2006,1117:

115-120.

[6]YANGFQ,LISP,CHENY,etal.IdentificationandquantitationofelevensesquiterpenesinthreespeciesofCurcumarhizomesbypressurizedliquidextractionandgaschromatography-massspectrometry[J].JournalofPharmaceuticalandBiomedicalAnalysis,2005,39:

552-558.

[7]YANGFQ,LISP,ZHAOJ,etal.OptimizationofGC-MSconditionsbasedonresolutionandstabilityofanalytesforsimultaneousdeterminationofninesesquiterpenoidsinthreespeciesofCurcumarhizomes[J].JournalofPharmaceuticalandBiomedicalAnalysis,2006.

[8]YANJZ,CHENG,TONGSQ,etal.PreparativeisolationandpurificationofgermacroneandcurdionefromtheessentialoiloftherhizomesofCurcumawenyujinbyhigh-speedcounter-currentchromatography[J].JournalofChromatographyA,2005,1070:

207-210.

[9]YANGFQ,WANGYT,LISP.Simultaneousdeterminationof11characteristiccomponentsinthreespeciesofCurcumarhizomesusingpressurizedliquidextractionandhigh-performanceliquidchromatography[J].JournalofChromatographyA,2006,1134:

226-231.

[10]YOUJ,CUIFD,HANX,etal.Studyofthepreparationofsustained-releasemicrospherecontainingzedoaryturmericoilbytheemulsion-solvent-diffusionmethodandevaluationoftheself-emulsificationandbioavailabilityoftheoil[J].ColloidsandSurfacesB:

Biointerfaces,2006,48:

35-41.

[11]WANGK,LIZ,CHENYR,etal.Thepharmacokineticsofanovelanti-tumoragent,β-elemene,inSprague-Dawleyrats[J].Biopharm.DrugDispos,2005,26:

301-307.

[12]YANGFQ,LISP,CHENY,etal.Quantitativedeterminationofcurcumol,germacroneandcurdionefromZedoaryRhizomebyGC-MS[J].ChinJPharmAnal,2005,25（7）:

827-830.

[13]TANM,GUOZT,SHILC,etal.Effectoflocalarterialinfusionofβ-elemeneonbreastcancertissueinhibitionandcellapoptosisandproliferation[J].JournalofGuangzhouUniversityofTraditionalChineseMedicine,2000,17（3）:

250-252.

[14]SONGS,LUTL,LIL.Analgesicandanti-inflammatoryeffectsofdifferentkindsRhizomaCurcumae[J].ChineseArchivesofTraditionalChineseMedicine,2005,23（3）:

443-444.

[15]WEIYP,LUOZC.StudyonanticandidaactivityofCurcumazedoariavolatileoilinvitro[J].ChinaJLeprSkinDis,2005,21（7）:

524-526.

[16]WANGJ,WANGSQ,NIH,etal.ExperimentalresearchofEzhu（turmericrhizome）naphthaoninhibitingingrowthofhumancarcinomacellsSMMC-7721[J].TianjinJournalofTraditionalChineseMedicine,2003,20

（1）:

48-51.

[17]LIL,LUTL,BIANHM,etal.Studyonactiveingredientsofblood-activatingandstasis-eliminationinRhizomaCurcumae[J].ActaUniversitatisTraditionisMedicalisSinensisPharmacologiaequeShanghai,2004,18（3）:

40-42.

[18]YANGL,QIANW,HOUXH,etal.EffectofextractsofRhizomacurcumaeonangiotensiaIIandtypeIreceptorexpressioninratliverfibrosisinducedbyCCl4[J].ChinJHepatol,2006,14（4）:

303-305.

[19]ZHOUH,SUNH,ZHONGY.In-vitroinhibitoryeffectofOleumCurcumaeAromaticaeonLeukemiacellstrain[J].JournalofGuangzhouUniversityofTraditionalChineseMedicine,2004,21

（2）:

131-133.

[20]ZHAOJL,CHENJH,SUNBG,etal.TheeffectofoleumcurcumaearomaticaeoilontypeIandtypeIIIcollagenininjuredratarteries[J].ChinJInterventCardiol,2004,12（6）:

359-362.

[21]ZHAOH,TANGWX.AinvitrostudyofthesuppressingroleofEleo-ZedoaryonScelllineRL-95-2’scellcycle[J].JournalofPracticalObstetricsandGynecology,2006,22（3）:

158-160.

[22]XIANGCY.Progressofpharmacologicalstudyandclinicalapplicationofcurzereneanditspreparation[J].HunanGuidingJournalofTMC,2004,10（8）:

48-49.

[23]HEXQ.Compatiblestabilitiesofzedoaryturmericoilandglucoseinjectionmixingwithsevenkindsofantibacterialdrugs[J].ChineseJournalofClinicalPharmacy,2005,14（4）:

252-254.

[24]SHILC,WANGB,TANGM,etal.MolecularmechanismofCurcumaAramaticaoiloninhibitingcellproliferationofhepatomainmice[J].ChinJNatMed,2002,4（4）:

206-207.

[25]ZHAOJL,LUOY,FUJN,etal.TheeffectsofOleumCurcumaeAromaticaeoilinjectiononinjuredratarteriesandcollagensafterballoonangioplasty[J].JClinCardiol（China）,2004,20（8）:

551-553.

[26]FENGG,HUANGT,LUHD,etal.ExperimentalstudyoninhibitingangiogenesisinmiceS180sarcomabycurcumaphaeocaulisvaleton[J].CancerResearchandClinic,2005,17（4）:

233-235.

[27]LUTL,MAOCQ,BIANHM,etal.Pharmacokineticstudiesoncurcuminincurcumaphaeocaulidinrats[J].ChineseTraditionalandHerbalDrugs,2005,36（8）:

1157-1158.

[28]HUANGSG,LISP,LIJ,etal.DeterminationofcurcumolandgermacroneinZedoaryTurmericoilandglucoseinjectionbyRP-HPLC[J].ChineseTraditionalPatentMedicine,2005,27（10）:

1141-1143.

[29]ZHUYE,ZHUXP.DeterminationofcurcumolinRhizomaCurcumaebyGC[J].ChinaJournalofChineseMateriaMedica,2006,31（5）:

389-390.

[30]WEIFX,DENGXL,CHENX,etal.DeterminationofelementinessentialoilfromcurcumabyGC[J].JournalofHebeiUniversityofScienceandTechnology,2005,26（3）:

219-221.

[31]NIEXH,AOZH,YINGY,etal.EffectofextractiontechniquesonthecomponentsandantitumoractivityinvitroofvolatileoilfromCurcumaWenyujin[J].PharmaceuticalBiotechnology,2003,10（3）:

152-154.

[32]XULC,BIANKJ,LIUZM,etal.TheinhibitoryeffectofthecurcumolonwomencancercellsandsynthesisofRNA[J].Tumor,2005,25（6）:

570-572.

[33]YOUJ,LIQP,YUYW,etal.PharmacokineticstudiesofzedoaryturmericoilbyHPLC[J].ChinPharmJ,2005,40（5）:

380-382.

[34]YOUJ,LIQP,YUYW,etal.Absorptionofzedoaryturmericoilinratintestineusinginsitusinglepassperfusionmodel[J].ActaPharmaceuticaSinica,2004,39（10）:

849-853.

[35]YANGFQ,LISP,CHENY,etal.ThefingerprintofEzhubyGC-MS[J].ActaPharmaceuticaSinica,2005,40（11）:

1013-1018.

[36]PENGBX,ZHOUX,WANGDP,etal.StudiesonthechemicalconstituentsoftheCurcumaphaeocaulisvaleton[J].LishizhenMedicineandMateriaMedicaResearch,2005,16（11）:

1091-1092.

[37]ZHANGXN.Ezhuoilnanocapsulefreeze-driedpowderinjectionanditspreparationprocess:

China,01131732.9[P].2003-04-16.

[38]DONGYJ.FormulationofEzhuoilhydroxypropyl-β-cyclodextrininclusioncompoundandpreparationmethods:

China,02109680.5[P].2005-04-06.

[39]GOUDH.Ananti-virussoft-gelcapsuleofEzhuoil:

China,02132406.9[P].2003-03-05.

[40]QUJZ,ZHANGBW,SHENXG.Ezhuoildrop-pillanditspreparationprocedure:

China,2004,200310115168.9[P].2004-11-10.

[41]SHAXY,FANGXL,WUYJ.Theinvitrokineticsofuptake,transportandeffluxof9-nitrocamptothecininCaco-2cellmodel[J].ActaPharmaceuticaSinica,2004,39（10）:

839-843.

[42]LIUZW,CHENBH.Caco-2cellmonolayersandit’sapplicationintoxicologicalresearch[J].JournalofHygieneResearch,2004,33（6）:

756-759.

[43]XIEHT,WANGGJ,ZHAOXC,etal.StudyonuptakeandmetabolismofginsenosideRg3[J].ChinJClinPharmacolTher,2004,9（3）:

257-260.

[44]GUANS,CHENX,HUANGM.Caco-2cellmodel—aneffectivetoolfortheresearchofdrugabsorption[J].ChinesePharmacologicalBulletin,2004,20（6）:

609-614.

[45]GAOK,SUNJ,HEZG.ImportantapplicationofCaco-2cellmonolayersinthestudyoftheintestinaloralabsorption[J].JournalofShenyangPharmaceuticalUniversity,2005,22（6）:

469-474.

[46]LIAOS,XIEJW.ApplicationofCaco-2cellmodelindruginvitroresearch[J].ChineseJournalofNewDrugs,2005,14（4）:

416-419.

[47]MUYP,WUG,ZHOULS,etal.ApplicationofCaco-2cellmodelindrugresearch[J].ChinesePharmacologicalBulletin,2005,21（5）:

536-539.

[48]WANGC,QIUZY.DevelpomentofresearchesinCaco-2cellmodel[J].JBiomedEng,2005,22（3）:

633-636.

[49]LIL,YUANY,JIANGXH.AbsorptionmechanismofliposolublecomponentsofSalviamiltiorrhizawithCaco-2cellmodel[J].ChinPharmJ,2006,41

（2）:

108-112.

[50]WANGLY,GUANS,HUANGM,etal.IntestinalabsorptionandmechanicsmofpsoralenusingCaco-2monolayermodel[J].ChinPharmJ,2005,40（24）:

1868-1870.

[51]WANGY,LIZR,PANFY,etal.AstudyontranscellulartransportationofinsulinliposomesusingCaco-2cellmodel[J].ChinesePharmacologicalBulletin,2005,21

（1）:

78-81.

[52]CHENJY,LIYQ,HUM.P-glycoprotein-mediatedtransepithelialtransportofAG337,anovelanticanceragent,inCaco-2cellculturemodel[J].ChineseJournalofClinicalPharmacy,2000,9（3）:

168-171.

[53]SHENK,WANGJT.Progressinexperimentalmethodsforstudyofdrugs’intestinalabsorption[J].ChineseJournalofNewDrugs,2003,12（12）:

988-991.

[54]YANGJB,YAOJ,YANGJ.Inv